Utilization of a peptide lead for the discovery of a novel PTP1B-binding motif

Journal of Medicinal Chemistry

Volumn 44, Issue 18, 2001, Pages 2869-2878

  Gao, Y ^a   Voigt, J ^a   Zhao, H ^a   Pais, G C G ^a   Zhang, X ^a   Wu, L ^b   Zhang, Z Y ^b   Burke Jr , T R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 CARBOXY 2 NAPHTHOIC ACID; 5 CARBOXY 6 CARBOXYMETHYLOXY 2 NAPHTHOIC ACID; 6 CARBOXY 1 NAPHTHOIC ACID; EPIDERMAL GROWTH FACTOR; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; ENZYME ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MOLECULAR MODEL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOSPECIFICITY; STRUCTURE ANALYSIS;

CATALYTIC DOMAIN; ENZYME INHIBITORS; HUMANS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR MIMICRY; NAPHTHALENES; OLIGOPEPTIDES; PROTEIN BINDING; PROTEIN-TYROSINE-PHOSPHATASE; RECOMBINANT PROTEINS;

EID: 0035974741     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm010020r     Document Type: Article

References (35)

1. Phosphotyrosyl-based motifs in the structure-based design of protein-tyrosine phosphatase inhibitors
2. Exploration of novel ligand binding modes leading to potent small molecule bis-carboxy naphthalene PTP1B-inhibitors
3. Protein-tyrosine phosphatases: Structure, mechanism, and inhibitor discovery
4. Protein tyrosine phosphatase inhibition
5. Crystal Structure of Human Protein Tyrosine Phosphatase 1B
6. Protein tyrosine phosphatase-1B in diabetes
7. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B
8. Phosphoryltyrosyl mimetics as signaling modulators and potential antitumor agents
9. Protein-tyrosine-phosphatase substrate-specificity-size and phosphotyrosine positioning requirements in peptide-substrates
10. Protein-tyrosine phosphatase inhibition by a peptide containing the phosphotyrosyl mimetic, O-malonyltyrosine (OMT)
11. 4′-O-[2-(2-fluoromalonyl)]-L-tyrosine: A phosphotyrosyl mimic for the preparation of signal transduction inhibitory peptides
12. 2Pmp
13. Phosphonate inhibitors of protein-tyrosine and serine/threonine phosphatases
14. Examination of novel nonphosphorus-containing phosphotyrosyl mimetics against protein-tyrosine phosphatase-1B and demonstration of differential affinities toward Grb2 SH2 domains
15. Enantioselective synthesis of nonphosphorus-containing phosphotyrosyl mimetics and their use in the preparation of tyrosine phosphatase inhibitory peptides
16. 2-(Arylalkylamino)adenosine-5′-uronamides - A new class of highly selective adenosine-A2 receptor ligands
17. Synthesis of 2,2′-diacyl-1,1′-biaryls -regiocontrolled protection of ketones in unsymmetrically substituted 9,10-phenanthrenequinones
18. Substituent effects in naphthalene I. The syntheses of 4,5,6,7 and 8-substituted 2-naphthoic acids
19. Piperidine-renin inhibitors compounds with improved physico-chemical properties
20. Chloramines as a source of iodine chloride. The preparation of iodo-phenols, -naphthols and -aromatic ethers by means of a chloramine and iodide
21. 2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 13 Some alkenyl derivatives with high invitro activity against anaerobic organisms
22. Research on nitro derivatives of biological interest. XXIX - Synthesis and activities against microoorganisms of hydroxylated derivatives of 2-nitronaphthofurans
23. Synthesis and biological evaluation of naphthyldesferrithiocin iron chelators
24. A new method for the preparation of tertiary butyl ethers and esters
25. 4
26. Structure-based design synthesis of small molecule protein-tyrosine phosphatase 1B inhibitors
27. Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics
28. Synthesis of Fmoc-protected 4-carboxydifluoromethyl-L- phenyl-alanine A phosphotyrosyl mimetic of potential use for signal transduction studies
29. 2-(Oxalylamino)-benzoic acid is a general, competitive inhibitor of protein-tyrosine phosphatases
30. 80 and flexible docking of 9-deazaguanine inhibitors into PNP
31. Monocarboxylic phosphotyrosyl mimetics in the design of Grb2 SH2 domain inhibitors
32. VHR and PTP1 protein phosphatases exhibit remarkably different active site specificities toward low molecular weight nonpeptidic substrates